Navigation Links
Expanding Health Coverage May Not Improve Access
Date:8/7/2009

Innovations in financing, delivery of care are needed to close gaps, experts say,,,,

FRIDAY, Aug. 7 (HealthDay News) -- Even if Congress extends health coverage to the nation's 46 million uninsured Americans, there's no guarantee that everyone will have access to care -- unless payment reforms and new models of care are adopted, some experts say.

Significantly expanding coverage without reforming health-care delivery is "a recipe for failure," said Alwyn Cassil, a spokeswoman for the Center for Studying Health System Change in Washington, D.C. "You won't be able to sustain the expanded coverage because it will just bankrupt us."

Spending on health care this year is projected to reach $2.5 trillion, or 17.6 percent of the U.S. gross domestic product, according to a Kaiser Family Foundation analysis of Medicare and Medicaid data. That's up from 7.2 percent in 1970, and by 2018 it could swell to one-fifth of the GDP, which is a measure of all goods and services produced in the United States.

Meanwhile, a worsening shortage of primary-care providers and rising demand for certain specialists will continue to strain the system, perhaps creating long waits for appointments.

The existing health-care delivery system cannot seamlessly respond to a surge in demand for services, said Jeffrey Bauer, a medical economist.

This is "one of the Achilles heels of reform," said Bauer, management consulting partner at Affiliated Computer Services Inc. and leader of the health futures practice at ACS Healthcare Solutions in Chicago.

"People are already strapped to get a doctor," Bauer said. "As more people have insurance, they will try to get appointments with more doctors, and that will lead to dramatic increases in the time it takes to get an appointment."

Depending on the coverage people have, where they live and whether they have an existing relationship with a physician, some Americans cou
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
2. Crowell & Morings Expanding Health Care Litigation Practice Gains Experienced Litigator
3. Microsoft and HIMSS Expanding Healthcare User Group Across EMEA
4. TraceSecurity Announces Partnership with PHNS Expanding Compliance Services to Hundreds of Healthcare Systems
5. cbm Expanding its Mandate
6. LogistiCare, a Subsidiary of Providence Service Corp., Opens Phoenix Call Center to Support Expanding Commercial Client Base
7. Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
8. Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
9. TeamStaff Renames Subsidiary to Reflect Expanding Government Services
10. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
11. Quantros Expanding Support for Alternative Web Browsers

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Expanding Health Coverage May Not Improve  Access
Expanding Health Coverage May Not Improve Access
(Date:11/25/2009)...5/PRNewswire/--TheBartleHallConventionCenterwillte...c.9-10,whenKansasCityhoststhelatestinaseriesofmass...liniceventhasthepotentialtobethebiggestoneyet,beca...donweekdaysinsteadofoveraweekend,"SheriWood,execut...dentoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--AnarticlebyJanetWoodco...ndResearch,titled"ADifficultBalance-PainManagement...eofTheNewEnglandJournalofMedicine. ,, (Logo: ht... ) ,, Inthearticle,WoodcockdiscussesFDAeffortst...sewhoneeditandmanagingtherisksposedbyvariousanalge...
(Date:11/25/2009)...dence of a statistically significant survival bene...strogen receptor (ER)-positive tumors had high lev...(ER-alpha S118-P), according to a brief communicat...f the National Cancer Institute . , Approximatel...fen. Preclinical studies have shown that ER-alpha ...
(Date:11/25/2009)...aluation and treatment clinics to resume Monday, N...) November 25, 2009 -- Centegra Health System is c...ccine shots at four Centegra Primary Care (CPC) va...e has arrived. The clinics are at CPC sites in Hun... be open as follows: ,   From 4:30 to ...
(Date:11/25/2009).../PRNewswire-USNewswire/--TheAmericanAssociationfor...2009,"S.2128,whichisdesignedtosubstantiallyimprove....ThebillwasintroducedbySen.GeorgeLeMieux(R-Fla.). ...ericanAssociationforHomecareoutlinedinits13-pointa...ongressinFebruary.Thoseprovisionsincludecallingfor...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...RMD ),announced today that on Thursday, May 1, 200...ter of fiscal year 2008, ended March 31, 2008. Res...0 p.m. Pacific Time and will,host a conference cal...e webcast on ResMed,s website at http://www.resme...
...s E-Card, WHITE PLAINS, N.Y., April 17 This Moth...available free and exclusively,from the March of D...www.MomYouRock.com, can be,personalized by upload... positions -- star of the show.,She is the star of...
...n,s cognitive development , , THURSDAY, Ap... while on certain seizure medications do not appea...a new study finds. , "Our early findings show bre...r, of the University of Florida at Gainesville, sa...
...ng viruses, CDC says , , THURSDAY, April 1...has been the worst in four years, due, in part, to...irculating strains of flu virus, U.S. health offic...ut it was 100 percent ineffective against influenz...
...poration (Nasdaq: DYNT ) today announced the intr...ealth System for treating back pain and the,Dynatr...., "The new DynaPro Spinal Health System uses a f...dall,executive vice president of sales and marketi...
...t,Hospice, Inc., the nation,s 1st hospice, proudly... first class of The Norma F. Pfriem,International ...ed by a,generous grant merited by the Connecticut ...hip was established at,the Connecticut Hospice sta...
Other Medicine News:Health News:ResMed to Webcast Third Quarter 2008 Earnings Conference Call 2Health News:Mom You Rock! 2Health News:Breast-Feeding While on Seizure Meds Doesn't Harm Babies 2Health News:Current Flu Season Worst in 4 Years 2Health News:Current Flu Season Worst in 4 Years 3Health News:Dynatronics Introduces New DynaPro Spinal Health System and X5 'Turbo' 2Health News:The Norma F. Pfriem International Fellowship in Hospice and Palliative Care Nursing 2
(Date:11/25/2009)...a-FirstCall/--ChinaSkyOne,Medical,Inc.("ChinaSkyOn...ullyintegratedpharmaceuticalcompanydevelopingandpr...ofChina("PRC"),today,announcedthattheCompanyrecent...fPharmaceuticalandBiologicalProducts("ICPBP")exami...umanProstateSpecific,Antigen(ColloidalGold)anditsD...
(Date:11/25/2009)...AccordingtoMillenniumResearchGroup(MRG),theglobala...early$3billionUSmarketfortraumafixationdeviceswill...etherecenteconomicslowdown.MRG,s USMarketsforTraum...highlydynamicoverthenextfiveyears,withcompetitorsi...dsegmentsofthetraumafixationmarket,fuelingmarketgr...
(Date:11/25/2009)...G,November25/PRNewswire/--,iThembaPharmaceuticals,...ttheyhavesignedacollaborativeagreementtojointlymar...sscomputationalchemistryandleaddiscoveryexpertise,...medicinaland,syntheticchemistrysupporttoprojectsid...ThembaPharmaceuticalsandPyxisDiscovery,alsoannounc...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2AUDIO from Medialink and Guardian 3A Breast Cancer Awareness Month Highlights Need for Critical Illness Insurance 59684 1International SOS Awarded TRICARE Overseas Program Contract 59681 1International SOS Awarded TRICARE Overseas Program Contract 59681 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 1FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 3FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 4FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 5FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 6FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 7
...IRE)--Jun 13, 2007 - EPIX,Pharmaceuticals, Inc. (N...ase 3 trial of PRX-00023, a novel long-acting 5-HT...at the 47th Annual New,Clinical Drug Evaluation Un...ting is sponsored by the National Institutes of,He...armacology., The presentation highlighted data fro...
..., WA -- (MARKET WIRE) -- June 14,2007 -- Targeted...rting data from the dose escalation arm of the ong...nts with inflammatory,arthritis. Philip J. Mease, ...ington School of Medicine, chief of rheumatology,c...acticing,physician with Seattle Rheumatology Assoc...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6
Anti-MPO - ELISA (P-ANCA)
Myeloperoxidase (MPO) Enzyme-Linked Immunosorbent Assay (ELISA)
Iso-Insulin ELISA
RIDASCREEN Anti-RSV IgM Assay
Medicine Products: